双参数MRI与多参数MRI在检测临床显著性前列腺癌中等效性能的研究
该回顾性研究纳入375例在MRI/超声融合靶向穿刺联合经会阴系统穿刺前接受mpMRI的患者,分析109个外周带DWI 3或DWI 4单发病灶。DWI 3/DCE-组、DWI 3/DCE+组、DWI 4/PIRADS 4组的csPCa检出率分别为10.3%、13.9%、55.9%,A与B组间无显著差异(p=0.625),B与C组间差异显著(p<0.001)。ROC分析和决策曲线分析显示,联合年龄、PSA密度和ADCmean的方法优于单一方法。
要点
- 外周带DWI 3病灶中,DCE序列未能提高csPCa检出率(DCE-组10.3% vs DCE+组13.9%,p=0.625)。
- DWI 4/PIRADS 4病灶的csPCa检出率为55.9%,显著高于DWI 3/DCE+组(p<0.001)。
- 联合年龄、PSA密度和ADCmean可改善csPCa检测。
诊断标准与关键数值
- PIRADS v2规定DWI 3外周带病灶根据DCE分为PIRADS 3(DCE-)或PIRADS 4(DCE+)。
- Group A(DWI 3/DCE-)csPCa检出率10.3%,Group B(DWI 3/DCE+)13.9%,Group C(DWI 4/PIRADS 4)55.9%。
- A vs B p=0.625,B vs C p<0.001。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: PIRADS v2 stipulates that dynamic contrast-enhanced (DCE) imaging be used to categorize diffusion-weighted-imaging (DWI) score 3 (DWI 3) peripheral zone (PZ) lesions as PIRADS score 3 (PIRADS 3; DCE -) or PIRADS 4 (DCE +). It's controversial for the value of DCE in improving clinically significant prostate cancer (csPCa) detection. We aimed to figure out whether DCE improves csPCa detection and explore new available measures to improve csPCa detection.
PATIENTS AND METHODS: We retrospectively enrolled 375 patients who underwent mp MRI before MRI/ultrasound (US) fusion-targeted biopsy (TB) with transperineal systematic biopsy (SB). All lesions were classified as DWI 3/DCE -, DWI 3/DCE +, DWI 4/PIRADS 4 lesions. Detection rates of csPCa for each lesion group were analyzed. The diagnostic performance of each approach was analyzed by receiver operating characteristics (ROC) analysis and decision curve analysis.
RESULTS: Totally, 109 DWI 3 or DWI 4 single lesions in PZ were analyzed (n = 109). The rates of csPCa detection for Group A, Group B, Group C is 10.3%, 13.9%, 55.9%, respectively (A vs. B, p = 0.625; B vs. C, p < 0.001). ROC analysis and decision curve analysis showed the method of combining Age, PSA Density (PSAD) and the mean apparent diffusion coefficient value (ADCmean) outperforms individual approaches for csPCa detection.
CONCLUSION: For DWI 3 lesions in PZ, DCE sequence has not additional value for improving detection of csPCa. The integration of clinical characteristics and bpMRI parameter improves the detection of csPCa.
引用
- Wang B, Gao J, Zhang Q, et al. Investigating the equivalent performance of biparametric compared to multiparametric MRI in detection of clinically significant prostate cancer. Abdom Radiol (NY). 2020. PMID: 31907568. doi:10.1007/s00261-019-02281-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。